Synthesis, solution conformations and hydrolytic stability of 3'-substituted 2'-deoxyribonucleosides. 1991

S Zavgorodny, and M Polianski, and V Kriukov, and P Oksman, and H Hakala, and H Lönnberg, and A Van Aerschot, and P Herdewijn, and A Azhayev
Chimtech Ltd, Moscow, USSR.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D003853 Deoxyribonucleosides A purine or pyrimidine base bonded to DEOXYRIBOSE.
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.

Related Publications

S Zavgorodny, and M Polianski, and V Kriukov, and P Oksman, and H Hakala, and H Lönnberg, and A Van Aerschot, and P Herdewijn, and A Azhayev
May 2008, The Journal of organic chemistry,
S Zavgorodny, and M Polianski, and V Kriukov, and P Oksman, and H Hakala, and H Lönnberg, and A Van Aerschot, and P Herdewijn, and A Azhayev
November 2004, Journal of medicinal chemistry,
S Zavgorodny, and M Polianski, and V Kriukov, and P Oksman, and H Hakala, and H Lönnberg, and A Van Aerschot, and P Herdewijn, and A Azhayev
December 1983, Journal of medicinal chemistry,
S Zavgorodny, and M Polianski, and V Kriukov, and P Oksman, and H Hakala, and H Lönnberg, and A Van Aerschot, and P Herdewijn, and A Azhayev
January 2021, Nucleosides, nucleotides & nucleic acids,
S Zavgorodny, and M Polianski, and V Kriukov, and P Oksman, and H Hakala, and H Lönnberg, and A Van Aerschot, and P Herdewijn, and A Azhayev
July 2005, Current protocols in nucleic acid chemistry,
S Zavgorodny, and M Polianski, and V Kriukov, and P Oksman, and H Hakala, and H Lönnberg, and A Van Aerschot, and P Herdewijn, and A Azhayev
June 1980, Biochemical pharmacology,
S Zavgorodny, and M Polianski, and V Kriukov, and P Oksman, and H Hakala, and H Lönnberg, and A Van Aerschot, and P Herdewijn, and A Azhayev
May 2003, Antiviral chemistry & chemotherapy,
S Zavgorodny, and M Polianski, and V Kriukov, and P Oksman, and H Hakala, and H Lönnberg, and A Van Aerschot, and P Herdewijn, and A Azhayev
February 1974, Die Pharmazie,
S Zavgorodny, and M Polianski, and V Kriukov, and P Oksman, and H Hakala, and H Lönnberg, and A Van Aerschot, and P Herdewijn, and A Azhayev
January 1967, Journal of medicinal chemistry,
S Zavgorodny, and M Polianski, and V Kriukov, and P Oksman, and H Hakala, and H Lönnberg, and A Van Aerschot, and P Herdewijn, and A Azhayev
March 2004, Biomaterials,
Copied contents to your clipboard!